Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cara Therapeutics (CARA)

Cara Therapeutics (CARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,836
  • Shares Outstanding, K 54,676
  • Annual Sales, $ 20,970 K
  • Annual Income, $ -118,510 K
  • 60-Month Beta 0.69
  • Price/Sales 0.90
  • Price/Cash Flow N/A
  • Price/Book 0.64
Trade CARA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.25
  • Most Recent Earnings $-0.56 on 05/13/24
  • Next Earnings Date 08/05/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 752.98% ( +238.02%)
  • Historical Volatility 210.29%
  • IV Percentile 94%
  • IV Rank 57.87%
  • IV High 1,285.41% on 06/13/24
  • IV Low 21.66% on 08/16/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 3
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 1,981
  • Open Int (30-Day) 1,918

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.29
  • Number of Estimates 3
  • High Estimate -0.23
  • Low Estimate -0.35
  • Prior Year -0.58
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2580 +32.98%
on 06/28/24
0.4100 -16.32%
on 07/11/24
+0.0661 (+23.86%)
since 06/21/24
3-Month
0.2400 +42.96%
on 06/20/24
0.8700 -60.56%
on 05/16/24
-0.3873 (-53.03%)
since 04/22/24
52-Week
0.2400 +42.96%
on 06/20/24
3.4500 -90.06%
on 07/31/23
-2.6069 (-88.37%)
since 07/21/23

Most Recent Stories

More News
Cara: Q1 Earnings Snapshot

Cara: Q1 Earnings Snapshot

CARA : 0.3490 (+1.31%)
Cara: Q4 Earnings Snapshot

Cara: Q4 Earnings Snapshot

CARA : 0.3490 (+1.31%)
Mira Pharmaceuticals Stock Is Soaring In November... Here's Why

Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m

MIRA : 3.3100 (+380.55%)
CARA : 0.3490 (+1.31%)
CRBP : 58.68 (+1.17%)
HRMY : 32.98 (+2.93%)
JAZZ : 108.71 (-0.28%)
Cara: Q3 Earnings Snapshot

Cara: Q3 Earnings Snapshot

CARA : 0.3490 (+1.31%)
Cara: Q2 Earnings Snapshot

Cara: Q2 Earnings Snapshot

CARA : 0.3490 (+1.31%)
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

/CNW/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that England's National Institute for...

CARA : 0.3490 (+1.31%)
Kapruvia® (difelikefalin) recommended by England's NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus

/PRNewswire/ -- Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Cara Therapeutics, Inc. (Nasdaq: CARA) today announced that England's National Institute...

CARA : 0.3490 (+1.31%)
Cara: Q1 Earnings Snapshot

Cara: Q1 Earnings Snapshot

CARA : 0.3490 (+1.31%)
Stocks Slide After the Fed Chairman Powell Warns Rates Will Likely Be Higher

Morning Markets The S&P 500 Index ( $SPX ) ( SPY ) today is down -0.41%, the Dow Jones Industrials Index ( $DOWI ) ( DIA ) is down -0.46%, and the Nasdaq 100 Index ( $IUXX ) ( QQQ ) is down -0.25%. Stock...

ESU24 : 5,604.75 (+0.92%)
NQU24 : 19,983.00 (+1.37%)
META : 488.67 (+2.49%)
DKS : 204.93 (-3.39%)
UAL : 48.32 (+0.81%)
TCOM : 47.42 (+4.54%)
SQSP : 43.91 (+0.16%)
DISH : 5.77 (+1.94%)
NTNX : 49.02 (+1.49%)
RIVN : 17.25 (+2.99%)
KEY : 15.72 (+0.83%)
ZYXI : 10.09 (-0.10%)
S&P Futures Tick Higher Ahead of Powell Testimony

March S&P 500 futures (ESH23) are trending up +0.21% this morning after three major U.S. benchmark indices ended the regular session mixed as market participants braced for Federal Reserve Chairman Jerome...

ESH23 : 3,957.05s (-0.09%)
AAPL : 224.31 (-0.06%)
MRK : 125.96 (+0.15%)
TSLA : 250.96 (+4.92%)
BNR.D.DX : 65.560 (+1.27%)
RIVN : 17.25 (+2.99%)
CARA : 0.3490 (+1.31%)
DXC : 19.52 (-0.76%)
ANET : 341.45 (+3.29%)
KRP : 16.92 (+0.83%)

Business Summary

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

See More

Key Turning Points

3rd Resistance Point 0.3705
2nd Resistance Point 0.3627
1st Resistance Point 0.3536
Last Price 0.3490
1st Support Level 0.3367
2nd Support Level 0.3289
3rd Support Level 0.3198

See More

52-Week High 3.4500
Fibonacci 61.8% 2.2238
Fibonacci 50% 1.8450
Fibonacci 38.2% 1.4662
Last Price 0.3490
52-Week Low 0.2400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar